CoChat
Sign Up
Cited by 121Bipolar Disorder and TreatmentTreatment of Major DepressionPersonality Disorders and Psychopathology

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Antidepressants worsen rapid-cycling course in bipolar depression: A STEP-BD randomized clinical trial

Open access
El-Mallakh, Rif S., Vöhringer, Paul A., Ostacher, Michael M., Baldassano, Claudia F., Holtzman, Niki S., Whitham, Elizabeth A., Thommi, Sairah B., Goodwin, Frederick K., Ghaemi, S. Nassir·2015·Journal of Affective Disorders
DOI 10.1016/j.jad.2015.04.054PMC PMC4519402
Open this paper in CoChat — free accountOpen PDF

Abstract

Background The use of antidepressants in rapid-cycling bipolar disorder has been controversial. We report the first randomized clinical trial with modern antidepressants on this topic.Methods As part of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) study, we analyzed, as an a priori secondary outcome, rapid cycling as a predictor of response in 68 patients randomized to continue vs. discontinue antidepressant treatment, after initial response for an acute major depressive episode. Outcomes assessed were percent time well and total number of episodes. All patients received standard mood stabilizers.Results In those continued on antidepressants (AD), rapid cycling (RC) subjects experienced 268% (3.14/1.17) more total mood episodes/year, and 293% (1.29/0.44) more depressive episodes/year, compared with non-rapid cycling (NRC) subjects (mean difference in depressive episodes per year RC vs. NRC was 0.85 ± 0.37 (SE), df = 28, p = 0.03). In the AD continuation group, RC patients also had 28.8% less time in remission than NRC patients (95% confidence intervals (9.9%, 46.5%), p = 0.004). No such differences between RC and NRC subjects were seen in the AD discontinuation group (Table 1). Analyses within the rapid-cycling subgroup alone were consistent with the above comparisons between RC and NRC subjects, stratified by maintenance antidepressant treatment, though limited by sample size.Conclusions In an a priori analysis, despite preselection for good antidepressant response and concurrent mood stabilizer treatment, antidepressant continuation in rapid-cycling was associated with worsened maintenance outcomes, especially for depressive morbidity, vs. antidepressant discontinuation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jad.2015.04.054

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 25 references

Cited by

Sorted by citations

Items 101–121 of 121

Related

See all

Metadata

Authors
El-Mallakh, R. S., Vöhringer, P. A., Ostacher, M. M., Baldassano, C. F., Holtzman, N. S., Whitham, E. A., Thommi, S. B., Goodwin, F. K., & Ghaemi, S. N.
Affiliations
  • Tufts Medical Center (US)
  • University of Pennsylvania (US)
  • George Washington University (US)
  • Tufts University (US)
ORCID
Venue
Journal of Affective Disorders
Publisher
Elsevier BV
Published
2015-09
Volume
184
Pages
318-321
ISSN
0165-0327 (ISSN-L)
DOI
10.1016/j.jad.2015.04.054
PMC
PMC4519402
OpenAlex
W1953160278
Cited by
120
References
25
Citations by year
2026: 9 · 2025: 10 · 2024: 15 · 2023: 12 · 2022: 12 · 2021: 9 · 2020: 9 · 2019: 11 · 2018: 11 · 2017: 8 · 2016: 11 · 2015: 3
FWCI
8.94
Type
journal article
Language
en
Update notices
erratum (2016-01-15)
Open access
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Journal of Affective Disorders (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Universidad de Chile (submittedVersion, cc-by-nc-nd)
Funders
NIH (MH-64189)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
Keywords
antidepressants, rapid cycling bipolar disorder, bipolar depression, antidepressant discontinuation, depressive episodes, mood stabilizers, STEP-BD, bipolar disorder treatment
MeSH terms
Adult, Antidepressive Agents, Bipolar Disorder, Female, Humans, Male, Symptom Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review